Unbound MEDLINE

A novel remote controlled capsule for site-specific drug delivery in human GI tract. International journal of pharmaceutics [Int J Pharm] Journal article

 
TitleA novel remote controlled capsule for site-specific drug delivery in human GI tract.
Author(s)Pi X, Liu H, Wei K, Lin Y, Zheng X, Wen Z 
InstitutionLaboratory of Pharmaceutical and Controlled Release Technology, Key Laboratory of Biorheological Science and Technology of Ministry of Education, College of Bioengineering of Chongqing University, Chongqing, PR China, 400044; Department of Mechanical Engineering, Vanderbilt University, Nashville, TN., U.S.A., 37235.
SourceInt J Pharm 2009 Aug 27.
AbstractRemote controlled capsule (RCC) has been extensively used in the field of site-specific drug delivery. It is a potent tool to study the regional drug absorption of the gastrointestinal (GI) tract that provides pharmaceutical scientists with significant pharmacokinetics data for oral drug formulation development. In present investigations, a patented novel RCC has been devised based on micro-electronic mechanical system (MEMS) technology. Micro-thrusters were for the first time exploited as drug release actuators of RCCs. As the micro-thruster is ignited by a radio frequency (RF) signal, the thrust force generated by the propellants pushes the piston forward and leads to a rapid and complete expulsion of therapeutic agents from the capsule. The micro-thruster merely consumes 120 mW for ignition and the duration time of drug release is decreased to less than 1 second. The feasibility of the novel RCC was evaluated through animal experiments in beagles using aminophylline as the model drug. The novel RCC developed is a promising alternative for site-specific drug delivery in human GI tract.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19716870
  
Advertise on this site.